GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Other Long Term Assets

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Other Long Term Assets : kr5.93 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Other Long Term Assets?

ExpreS2ion Biotech Holding AB's other long-term assets for the quarter that ended in Dec. 2024 was kr5.93 Mil.

ExpreS2ion Biotech Holding AB's quarterly other long-term assets declined from Jun. 2024 (kr5.88 Mil) to Sep. 2024 (kr5.84 Mil) but then increased from Sep. 2024 (kr5.84 Mil) to Dec. 2024 (kr5.93 Mil).

ExpreS2ion Biotech Holding AB's annual other long-term assets increased from Dec. 2022 (kr1.56 Mil) to Dec. 2023 (kr5.80 Mil) and increased from Dec. 2023 (kr5.80 Mil) to Dec. 2024 (kr5.93 Mil).


ExpreS2ion Biotech Holding AB Other Long Term Assets Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Other Long Term Assets Chart

ExpreS2ion Biotech Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 1.14 1.56 5.80 5.93

ExpreS2ion Biotech Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.80 5.96 5.88 5.84 5.93

ExpreS2ion Biotech Holding AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


ExpreS2ion Biotech Holding AB Business Description

Traded in Other Exchanges
N/A
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25
ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy; ES2B-I002, a Cytomegalovirus (CMV) vaccine; and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.

ExpreS2ion Biotech Holding AB Headlines

No Headlines